“…On the other hand, spirooxindoles represent one of the most attractive heterocyclic motifs which widely exist in alkaloids and pharmacologically interesting compounds such as cipargamin and satavaptan (Figure , IV – V ). , In recent decades, significant progress have been made for the synthesis of various functionalized spirooxindoles, owing to their diverse bioactivities and structural complexity. , Presumably, the combination of these two significant pharmaphores, i.e., [3,4]-fused oxindole and spirooxindole moieties, might produce a privileged structure possessing promising bioactivity. However, the synthesis of spirocyclic bisoxindoles featuring a [3,4]-fused oxindole moiety (Figure , VI ) poses a formidable challenge, and there has been no example available until now.…”